Global High-Priority Regulatory Events — February 11, 2026

12-02-2026

12-02-2026

12-02-2026

GHCL Ltd (BSE: 500171) has issued an intimation on February 12, 2026, regarding a reminder letter sent to shareholders for claiming unclaimed dividends. This is a routine compliance disclosure with no additional financial metrics, amounts, or impacts mentioned. No positive or negative performance indicators are provided in the filing.

11-02-2026

12-02-2026

12-02-2026

Baxter International Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007474), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the officer's name, position, reason for change, timing, financial metrics, or quantitative data are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Filing size: 1 MB
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

12-02-2026

12-02-2026

Yatharth Hospital & Trauma Care Services Ltd (BSE: 543950) has submitted the Monitoring Agency Report for the quarter ended December 31, 2025, under Regulation 30 (LODR), pertaining to its IPO. No specific financial metrics, utilization details, or performance indicators are disclosed in the announcement.

12-02-2026

12-02-2026

12-02-2026

Coinbase Global, Inc. filed an 8-K on February 12, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results and attaches relevant exhibits, but no specific revenue, earnings, guidance, or other metrics are detailed in the provided information. No positive or negative performance indicators, period-over-period changes, or strategic details are mentioned.

11-02-2026

HomeTrust Bancshares, Inc. filed an 8-K on February 11, 2026, reporting under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals involved, effective dates, or compensatory terms are disclosed. No financial metrics, quantitative impacts, or other changes are mentioned.

11-02-2026

AMERICAN REBEL HOLDINGS INC filed an 8-K on 2026-02-11 under Items 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals a core delisting event alongside equity sales and disclosures, with no quantitative financial metrics, transaction values, or performance comparisons disclosed. No positive or offsetting metrics are mentioned.

11-02-2026

Brag House Holdings, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-015027), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or terms were provided in the filing summary. Sector not specified.

11-02-2026

RE/MAX Holdings, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001104659-26-013546, Size: 185 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and any financial or compensatory terms are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or governance impacts were provided in the available information.

11-02-2026

Peapack Gladstone Financial Corp filed an 8-K on February 11, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

11-02-2026

Aqua Metals, Inc. filed an 8-K on February 11, 2026, reporting entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also discloses other events (Item 8.01) and provides financial statements and exhibits (Item 9.01). No quantitative metrics, deal terms, parties, or performance impacts—positive or negative—are disclosed.

11-02-2026

Biogen Inc. filed a Form 8-K on 2026-02-11 disclosing an unspecified officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

11-02-2026

Ernexa Therapeutics Inc. filed an 8-K on February 11, 2026 (AccNo: 0001493152-26-006227), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction value, financial impacts, or metrics. No positive, negative, or flat performance metrics are disclosed.

11-02-2026

Galecto, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits, likely related to the agreement. No specific terms, transaction values, financial impacts, or quantitative metrics are provided in the filing summary.

11-02-2026

STRATA Skin Sciences, Inc. filed a Form 8-K on 2026-02-11 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 8.01 reports Other Events. No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.

11-02-2026

Evolution Petroleum Corp filed an 8-K on February 11, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are disclosed.

• ·AccNo: 0001104659-26-013485
• ·File Size: 550 KB

11-02-2026

Tronox Holdings plc filed an 8-K on February 11, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. Specific details including officer names, positions, reasons for change, or any quantitative data are NOT_DISCLOSED.

11-02-2026

Community Financial System, Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are disclosed.

11-02-2026

Colombier Acquisition Corp. III filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-014983) under Item 8.01 Other Events, related to a merger/acquisition event. Item 9.01 discloses financial statements and exhibits. No specific deal structure, parties, valuation, financial metrics, or quantitative data are provided in the filing summary.

11-02-2026

USANA Health Sciences Inc filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative data are disclosed.

11-02-2026

Horizon Technology Finance Corp filed an 8-K on February 11, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or quantitative metrics are provided in the filing summary. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

11-02-2026

MARZETTI CO filed an 8-K on February 11, 2026, disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02. Other events are reported under Item 8.01, with financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

11-02-2026

La Rosa Holdings Corp. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are disclosed.

11-02-2026

Portillo's Inc. filed an 8-K on 2026-02-11 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's name, title, whether it is an appointment or resignation, reasons for the change, or any quantitative compensation data are disclosed. The filing appears routine with no mentioned positive or negative performance metrics tied to the change.

11-02-2026

AAR CORP filed an 8-K on February 11, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also covers Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on positions affected, names, reasons for change, quantitative data, or performance metrics are disclosed.

11-02-2026

Evergy, Inc. filed a Form 8-K on 2026-02-11 reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement (Item 2.03), with financial statements and exhibits attached (Item 9.01). No specific details, dollar values, parties, or impacts are disclosed. This multi-item filing signals changes in agreements and obligations, but lacks quantitative data for assessment.

11-02-2026

Navan, Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, appointment or resignation status, reasons, or any quantitative data are NOT_DISCLOSED.

11-02-2026

Cipher Mining Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on position, individual, or reasons provided. The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No quantitative metrics, performance comparisons, or further context on the change's implications are disclosed.

11-02-2026

Energy Vault Holdings, Inc. filed an 8-K on February 11, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction values, financial impacts, or metrics are provided in the filing summary. No positive or negative metrics, comparisons, or directional indicators are mentioned.

11-02-2026

BIO-TECHNE Corp filed an 8-K on 2026-02-11 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the key position affected, individual names, appointment/resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

11-02-2026

ZYNEX INC filed an 8-K on 2026-02-11 (AccNo: 0001104659-26-013411) disclosing a bankruptcy or receivership event under Item 1.03. No additional details on the type of proceedings, financial impacts, debts, assets, or restructuring plans are provided in the filing summary. This event represents a material adverse development with no counterbalancing positive metrics mentioned.

11-02-2026

Apple iSports Group, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001477932-26-000755), reporting under Item 1.02 the termination of a material definitive agreement. No details on the agreement's nature, parties, dollar value, strategic role, or financial implications were disclosed. This is a single-item mandatory disclosure with no other metrics or comparisons provided.

11-02-2026

COMMUNITY HEALTH SYSTEMS INC filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046661), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including key positions affected, names of individuals, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material data points are provided in the available information.

11-02-2026

Bravo Multinational Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals, reasons for change, or compensation are disclosed.

11-02-2026

CID Holdco, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.01 notice of delisting or failure to satisfy a continued listing rule or standard, with Item 9.01 providing financial statements and exhibits. No quantitative details such as transaction values, financial impacts, dollar amounts, or specific terms are disclosed. This multi-item filing suggests potential financial distress without offsetting positive metrics disclosed.

11-02-2026

National Bank Holdings Corp filed a Form 8-K on February 11, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, along with Regulation FD disclosure in Item 7.01 and exhibits in Item 9.01. No quantitative details such as transaction values, financial terms, or impacts on revenue, earnings, balance sheet, or guidance are disclosed. This multi-item filing signals significant contractual and financing activity but provides no metrics for positive or negative assessment.

11-02-2026

CNO Financial Group, Inc. filed an 8-K on 2026-02-11 disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on affected positions, names, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

• ·Sector: sector not specified
• ·Filing Accession Number: 0001224608-26-000011
• ·Filing Size: 484 KB

11-02-2026

Abpro Holdings, Inc. filed a Form 8-K on 2026-02-11 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, which is a material negative event signaling potential loss of exchange trading status. The filing is multi-item, also disclosing under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No quantitative financial metrics, transaction values, or other numerical data are disclosed.

11-02-2026

Balance Labs, Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included, but specific details on the affected position, appointment or resignation, reasons, or individuals involved are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or additional corporate actions were mentioned.

11-02-2026

Interactive Strength, Inc. filed an 8-K on 2026-02-11 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 3.02 (Unregistered Sales of Equity Securities). This multi-item filing indicates a likely financing-related transaction involving a new agreement, financial obligation, and equity issuance, but no quantitative details, terms, or impacts are disclosed. No positive or negative metrics, comparisons, or guidance changes are provided.

11-02-2026

Inception Growth Acquisition Ltd filed an 8-K on February 11, 2026, disclosing entry into a material definitive agreement under Item 1.01, amendments to articles of incorporation or bylaws and/or change in fiscal year under Item 5.03, submission of matters to a vote of security holders under Item 5.07, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties involved, valuations, synergies, or performance comparisons are disclosed in the provided filing summary. This appears to be a SPAC-related merger announcement based on company name and items, but all specifics are NOT_DISCLOSED.

11-02-2026

Teradata Corp filed an 8-K on February 11, 2026 (AccNo: 0001628280-26-007274), disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, financial metrics, dollar values, or impacts are disclosed in the provided filing summary.

11-02-2026

Intuitive Machines, Inc. filed an 8-K on 2026-02-11 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are explicitly stated. No positive or negative metrics, financial impacts, or scheduled events were mentioned.

11-02-2026

Phoenix Motor Inc. filed an 8-K on February 11, 2026 (AccNo: 0001493152-26-006203), reporting under Item 3.03 for material modifications to rights of security holders, Item 5.03 for amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 for financial statements and exhibits. This is a multi-item mandatory disclosure with no quantitative financial metrics, transaction values, or performance comparisons disclosed. Specific details on the nature, scope, or impact of the modifications or amendments are not provided.

11-02-2026

Local Bounti Corporation/DE filed a Form 8-K on 2026-02-11 under Items 3.01, 7.01, and 9.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, along with Regulation FD disclosure and financial statements/exhibits. This event signals non-compliance with exchange listing requirements, potentially leading to transfer to over-the-counter trading. No quantitative financial metrics, positive developments, or period-over-period comparisons were disclosed.

• ·AccNo: 0001628280-26-007269
• ·Filing size: 194 KB
• ·Multi-item 8-K filing (Items 3.01, 7.01, 9.01)

11-02-2026

Bleichroeder Acquisition Corp. II filed an 8-K on 2026-02-11 (AccNo: 0001213900-26-014891) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No quantitative metrics, financial data, personnel names, dates, or merger/acquisition details are explicitly stated in the filing summary provided. Sector is not specified, and no positive or negative performance indicators are mentioned.

11-02-2026

Mativ Holdings, Inc. filed an 8-K on 2026-02-11 disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details such as names, positions affected, reasons for change, or quantitative data are disclosed.

11-02-2026

Gladstone Investment Corporation filed an 8-K on February 11, 2026, reporting under Item 1.01 its entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details regarding the agreement's parties, terms, value, financial impacts, or any quantitative metrics are provided.

11-02-2026

AEye, Inc. filed an 8-K on February 11, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

11-02-2026

Southern California Edison Co filed an 8-K on 2026-02-11 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

11-02-2026

Halliburton Co filed an 8-K on 2026-02-11 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for change, effective dates, or quantitative details are disclosed in the provided filing summary. This appears to be a standard governance disclosure with no additional financial or operational metrics mentioned.

11-02-2026

Millerknoll, Inc. filed an 8-K on February 11, 2026 (AccNo: 0000066382-26-000031), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed.

11-02-2026

Independence Realty Trust, Inc. filed a multi-item Form 8-K on February 11, 2026, reporting entry into a material definitive agreement (Item 1.01) and termination of a material definitive agreement (Item 1.02), alongside results of operations and financial condition (Item 2.02) and creation of a direct financial obligation (Item 2.03). Regulation FD disclosure (Item 7.01) was also included with financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, dollar values, or performance comparisons are disclosed.

11-02-2026

Envoy Medical, Inc. filed an 8-K on 2026-02-11 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, performance comparisons, or other financial data are mentioned.

11-02-2026

Star Gold Corp. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are provided in the filing summary. Sector is not specified.

11-02-2026

Microchip Technology Inc filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-046713), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, impacts, or quantitative metrics disclosed in the provided information.

11-02-2026

TreeHouse Foods, Inc. filed an 8-K on February 11, 2026, disclosing entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports creation of a direct financial obligation (Item 2.03), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), and departures/elections of directors/officers or compensatory arrangements (Item 5.02), along with amendments to articles of incorporation (Item 5.03). No quantitative financial metrics, deal values, parties, or performance comparisons were disclosed.

12-02-2026

Southwest Gas Holdings, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047540), reporting under Item 1.02 the termination of a material definitive agreement. No financial terms, parties involved, strategic rationale, or impacts are disclosed.

12-02-2026

Amrize Ltd filed a Form 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), names of individuals, reasons for the change, or any quantitative impacts are provided in the filing summary. No positive or negative metrics, financial data, or governance implications are mentioned.

12-02-2026

Applied Materials Inc./DE filed a Form 8-K on February 12, 2026 (AccNo: 0001628280-26-007444, Size: 208 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, disclosures, financial statements, or exhibits are provided. This is a multi-item filing with no quantitative metrics, positive or negative, disclosed.

12-02-2026

Oak Woods Acquisition Corp filed an 8-K on 2026-02-12 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 9.01 includes financial statements and exhibits. No merger/acquisition details, quantitative metrics, positive or negative performance indicators, or period-over-period comparisons are explicitly stated in the filing summary.

12-02-2026

FTAI Aviation Ltd. filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions, reasons for changes, timing, or quantitative details such as compensation amounts were provided. No positive or negative metrics, performance context, or governance implications were mentioned.

12-02-2026

AFFILIATED MANAGERS GROUP, INC. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047590) under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, titles, reasons for changes, effective dates, or quantitative impacts are provided. No financial metrics, performance comparisons, or other operational data are mentioned.

12-02-2026

TransUnion filed a multi-item 8-K on February 12, 2026 (AccNo: 0001552033-26-000006), reporting entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with Regulation FD disclosure under Item 7.01. Specific details on the agreement terms, transaction size, financial results, and obligation amounts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or directional impacts (positive, negative, or flat) are provided in the filing summary.

12-02-2026

AquaBounty Technologies Inc. filed an 8-K on February 12, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial metrics, positive or negative impacts, or quantitative data are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or guidance provided.

12-02-2026

CarMax Inc filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Arvinas, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007463), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. This represents a standard disclosure requirement without additional context on positive or negative implications.

12-02-2026

DANA Inc filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, and any governance implications are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.

12-02-2026

FirstEnergy Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics are mentioned.

12-02-2026

Alkermes plc filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), but also termination of a prior material definitive agreement (Item 1.02) and creation of a direct financial obligation (Item 2.03). Regulation FD disclosure was provided (Item 7.01) with financial statements and exhibits (Item 9.01). No specific transaction details, parties, values, or metrics are disclosed.

12-02-2026

Axos Financial, Inc. filed a Form 8-K on 2026-02-12 under Item 1.01 disclosing entry into a Material Definitive Agreement. Item 9.01 provides Financial Statements and Exhibits. No further details on the agreement, transaction size, financial impacts, or other metrics are disclosed.

12-02-2026

EDAP TMS SA filed an 8-K on 2026-02-12 disclosing an officer change or related matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, whether it was an appointment or resignation, reasons for the change, or any quantitative financial impacts are disclosed. Item 7.01 suggests potential material non-public information was shared, but content is NOT_DISCLOSED.

12-02-2026

Avadel Pharmaceuticals PLC filed an 8-K on 2026-02-12 disclosing the completion of an acquisition or disposition of assets under Item 2.01, changes in control of the registrant under Item 5.01, and notice of delisting or failure to satisfy listing standards under Item 3.01. The filing also reports termination of a material definitive agreement (Item 1.02), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No quantitative financial metrics, deal values, parties, or specific terms were disclosed.

12-02-2026

Bloomin' Brands, Inc. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons, or timing are NOT_DISCLOSED.

12-02-2026

Onconetix, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015212, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01 and other events under Item 8.01. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, positive or negative impacts, or quantitative data are disclosed.

12-02-2026

12-02-2026

Voyager Therapeutics, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, appointment or resignation, reasons, timing, or any quantitative data such as compensation amounts or share counts are disclosed. Sector is not specified.

12-02-2026

Evolv Technologies Holdings, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. Specific details regarding the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Cue Biopharma, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, effective dates, or any financial metrics are provided in the filing summary. This represents a standard governance disclosure with no quantified positive or negative impacts mentioned.

12-02-2026

Aardvark Therapeutics, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, whether it is an appointment or resignation, reasons for the change, named individuals, effective dates, or any quantitative data such as compensation amounts are disclosed. No financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

VerifyMe, Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a new material definitive agreement (Item 1.01) while simultaneously terminating another material definitive agreement (Item 1.02), alongside changes involving departure or election of directors/officers and compensatory arrangements (Item 5.02), and Regulation FD disclosure (Item 7.01). No quantitative financial details, transaction values, or specific impacts are provided in the filing summary. Item 9.01 lists financial statements and exhibits, but contents are not detailed.

12-02-2026

Xerox Holdings Corp filed a Form 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided in the available filing summary.

12-02-2026

Tectonic Financial, Inc. filed an 8-K on February 12, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and lists financial statements and exhibits under Item 9.01. No quantitative details, dollar values, strategic impacts, or performance metrics are disclosed.

12-02-2026

Sprout Social, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001517375-26-000003), disclosing results of operations and financial condition under Item 2.02 alongside an officer change or related event under Item 5.02. Item 5.02 covers potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, but specific details including names, positions, reasons, and timing are NOT_DISCLOSED. No financial metrics, quantitative changes, or performance comparisons are provided in the available information.

12-02-2026

Sonoco Products Co filed an 8-K on February 12, 2026 (AccNo: 0001104659-26-013958, Size: 226 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officers, positions, reasons for change, appointments, resignations, or any quantitative financial metrics are disclosed. The event is informational with no mentioned positive or negative performance indicators.

12-02-2026

Childrens Place, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed.

12-02-2026

Totaligent, Inc. filed an 8-K on February 12, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's terms, parties, value, strategic importance, or financial impact were disclosed. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

12-02-2026

Under Armour, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer, position affected, reason for change, or any quantitative metrics are disclosed.

12-02-2026

Contango ORE, Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, financial impacts, or events are provided in the available information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

12-02-2026

Indaptus Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001493152-26-006330), reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This is a multi-item filing focused on material contractual and equity events without specified positive or negative metrics.

12-02-2026

12-02-2026

Aspire Biopharma Holdings, Inc. filed a multi-item Form 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures or appointments of directors/officers or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

12-02-2026

Fresh Del Monte Produce Inc filed an 8-K on 2026-02-12 disclosing entry into a material definitive agreement under Item 1.01. The filing also includes financial statements and exhibits under Item 9.01. No details on the agreement terms, parties, financial impact, or quantitative metrics are provided.

12-02-2026

FVCBankcorp, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001675644-26-000006, size: 25 MB), reporting multiple items including entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative metrics, transaction details, financial impacts, period-over-period comparisons, or specific terms are disclosed.

• ·Multi-item 8-K filing (5 items reported)
• ·File size: 25 MB (suggests detailed exhibits)

12-02-2026

CIM Real Estate Finance Trust, Inc. filed an 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No transaction details, dollar values, financial metrics, or impacts are disclosed.

12-02-2026

Yum Brands Inc. filed an 8-K on February 12, 2026 (AccNo: 0001041061-26-000069), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, reasons for change, or any quantitative metrics such as compensation amounts are disclosed in the provided filing summary. No positive or negative performance metrics, comparisons, or financial impacts are mentioned.

12-02-2026

FIRST US BANCSHARES, INC. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics are disclosed.

12-02-2026

Tennessee Valley Authority filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed in the provided filing information. No positive or negative performance metrics are mentioned.

12-02-2026

TRANSUITE.ORG INC. filed a Form 8-K on 2026-02-12 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for change, or any quantitative data are provided. No positive or negative metrics mentioned.

12-02-2026

Pegasystems Inc filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual involved, reason for change, or any quantitative metrics are disclosed.

12-02-2026

Verses AI Inc. filed an 8-K on 2026-02-12 disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, names, reasons for change, or any quantitative metrics are provided. No positive or negative performance metrics mentioned.

12-02-2026

SPS COMMERCE INC filed an 8-K on 2026-02-12 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details regarding the officer change, including position affected, appointment or resignation status, reasons, timing, financial results, or any metrics are NOT_DISCLOSED. The filing size is 701 KB with AccNo 0001092699-26-000007.

12-02-2026

Kenvue Inc. filed an 8-K on 2026-02-12 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

• ·Filing Accession Number: 0000950157-26-000133
• ·File Size: 155 KB
• ·Sector: NOT_DISCLOSED

12-02-2026

Jet.AI Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, which may have strategic implications, but also a notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, signaling potential removal from exchange listing and liquidity risks. Item 8.01 reports other events and Item 9.01 includes financial statements and exhibits. No transaction values, financial impacts, or specific details on the agreement or delisting triggers are disclosed.

12-02-2026

Galera Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048696), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected, names of individuals, nature of change (appointment or resignation), reasons, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

12-02-2026

Repay Holdings Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

12-02-2026

MASCO CORP /DE/ filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics, financial impacts, or further context are mentioned.

12-02-2026

Beam Therapeutics Inc. filed an 8-K on 2026-02-12 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement's terms, parties, value, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons are provided.

• ·AccNo: 0001193125-26-048684
• ·Filing size: 230 KB

12-02-2026

Pro-Dex Inc filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, completion of an acquisition or disposition of assets under Item 2.01, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Regulation FD disclosure was provided under Item 7.01, with financial statements and exhibits attached under Item 9.01. No specific transaction details, parties, values, or metrics are disclosed in the provided filing summary.

12-02-2026

Teladoc Health, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001477449-26-000002), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are disclosed. No quantitative metrics, performance comparisons, or other financial data are mentioned.

12-02-2026

Edgemode, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are provided.

12-02-2026

Solaris Energy Infrastructure, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048667), reporting under Item 1.01 entry into a Material Definitive Agreement. No details on the core event, transaction value, parties involved, financial impact, or strategic importance are disclosed. No quantitative metrics, period-over-period comparisons, or other data points such as revenue, earnings, guidance, or balance sheet effects are provided.

12-02-2026

Rambus Inc filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

12-02-2026

Public Storage filed an 8-K on February 12, 2026, under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements; Item 7.01 for Regulation FD disclosure; Item 8.01 for other events; and Item 9.01 for financial statements and exhibits. No specific details on the officer affected, position, appointment/resignation status, reasons, or any financial metrics are disclosed. This filing provides limited transparency on the leadership change event.

12-02-2026

agilon health, inc. filed a Form 8-K on February 12, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, parties, terms, or financial impacts are disclosed in the provided filing summary.

• ·Accession Number: 0001628280-26-007671
• ·Multi-item 8-K filing (Items 1.01, 2.03, 9.01)
• ·Sector: NOT_DISCLOSED

12-02-2026

CVR Energy Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with exhibits under Item 9.01. This multi-item filing signals a significant contractual commitment and new financial liability, but no details on terms, size, or impacts are provided. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

12-02-2026

Thermo Fisher Scientific Inc. filed an 8-K on February 12, 2026 (AccNo: 0001140361-26-005014), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing summary.

12-02-2026

VenHub Global, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015576), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction values, financial metrics, or performance comparisons disclosed. No positive or negative metrics are provided.

12-02-2026

Fortune Brands Innovations, Inc. filed an 8-K on February 12, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, appointment or resignation status, timing, and any financial metrics are NOT_DISCLOSED. No positive or negative metrics, scheduled events, or quantitative data are provided in the filing summary.

12-02-2026

Sphere 3D Corp. filed a Form 8-K on February 12, 2026, reporting under Item 3.03 material modifications to the rights of security holders and under Item 5.03 amendments to its articles of incorporation or bylaws or a change in fiscal year. The filing also includes Item 7.01 for Regulation FD disclosure and Item 9.01 for financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the modifications, impacts, or exhibits were disclosed in the provided information.

12-02-2026

Catheter Precision, Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). While the material agreement may signal strategic progress, the unregistered equity sales raise potential dilution concerns and the governance changes introduce uncertainty without specified details. No quantitative transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed.

12-02-2026

Bain Capital GSS Investment Corp. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed.

12-02-2026

Lunai Bioworks Inc. filed a Form 8-K on 2026-02-12 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, which represents a material negative event signaling potential removal from U.S. exchange trading. Item 7.01 includes a Regulation FD Disclosure. No financial metrics, positive developments, or quantitative details are disclosed.

12-02-2026

FrontView REIT, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048763), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are disclosed in the provided information. No positive or negative performance metrics, period-over-period comparisons, or guidance changes are mentioned.

12-02-2026

Bright Horizons Family Solutions Inc. filed an 8-K on February 12, 2026, reporting results of operations and financial condition under Item 2.02 and officer departures, elections, appointments, or compensatory arrangements under Item 5.02. Financial statements and exhibits are provided under Item 9.01. No specific details on the officer change (e.g., position, reason, internal/external), financial metrics, or period-over-period comparisons are disclosed.

12-02-2026

BioMarin Pharmaceutical Inc filed an 8-K on February 12, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for material events, but specific details on the agreement, transaction size, parties, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

12-02-2026

NMI Holdings, Inc. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details regarding the key position affected, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

12-02-2026

Constellation Brands, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details regarding the key position affected, whether it is an appointment or resignation, reasons for the change, or any governance implications are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Norwegian Cruise Line Holdings Ltd. filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or financial metrics are provided in the filing summary. Sector not specified.

12-02-2026

Ameriprise Financial Inc filed an 8-K on February 12, 2026 (AccNo: 0001104659-26-014312), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are provided. No quantitative metrics, performance comparisons, or other financial data are mentioned.

12-02-2026

SOLV Energy, Inc. filed a multi-item Form 8-K on 2026-02-12 reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers including compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative transaction values, financial impacts, share counts, or performance metrics are disclosed. The filing covers both potentially strategic developments and governance/equity changes with unknown directional implications.

12-02-2026

Grand Canyon Education, Inc. filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Ashford Hospitality Trust Inc. filed an 8-K on February 12, 2026, announcing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides financial statements and exhibits related to the transaction. No specific details on parties, deal value, terms, or financial impacts are disclosed.

12-02-2026

Digimarc CORP filed an 8-K on February 12, 2026 (AccNo: 0001437749-26-003950), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

12-02-2026

Equinix Inc filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed.

12-02-2026

Celcuity Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. Specific details including names, positions, reasons, or compensation are NOT_DISCLOSED.

12-02-2026

Middlefield Banc Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.

12-02-2026

Carnival PLC filed an 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.03 material modifications to rights of security holders, with exhibits provided under Item 9.01. No specific details, financial terms, quantitative metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the filing summary. This is a multi-item mandatory filing with no further transaction or impact data available.

12-02-2026

Cineverse Corp. filed a Form 8-K on 2026-02-12 reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.02 Results of Operations and Financial Condition, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, financial metrics, or period-over-period comparisons disclosed in the provided information. No positive or negative metrics are available.

12-02-2026

MVB Financial Corp filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected officer, position, reason for change, or timing are disclosed.

12-02-2026

Origin Materials, Inc. filed a multi-item Form 8-K on February 12, 2026, reporting costs associated with exit or disposal activities under Item 2.05 alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. This indicates a material restructuring or disposal event with associated costs, which is typically negative for earnings, while Item 7.01 may provide additional voluntary context. No specific dollar values, impacts, metrics, or period-over-period comparisons are disclosed.

12-02-2026

GEO Group Inc filed an 8-K on February 12, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details such as names, titles, reasons for change, timing, or any quantitative data are disclosed.

12-02-2026

Keurig Dr Pepper Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on affected positions, individuals involved, reasons for change, or financial impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Republic Services, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), with no specific details on the officer, position, or reason provided. The filing also covers Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), filed under AccNo: 0001060391-26-000066 (size: 540 KB). No quantitative metrics, financial impacts, or performance comparisons are mentioned.

• ·Filing AccNo: 0001060391-26-000066
• ·File Size: 540 KB
• ·Event Date: 2026-02-12
• ·Sector: NOT_DISCLOSED

12-02-2026

Vail Resorts Inc filed an 8-K on February 12, 2026 (AccNo: 0000812011-26-000010), reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Registrant), with Item 9.01 providing Financial Statements and Exhibits. No specific details on the nature of the agreement, transaction value, financial terms, or impacts are disclosed. No quantitative metrics, period-over-period comparisons, or other performance data are mentioned.

12-02-2026

Xilio Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048942), disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, financial impacts, or other quantitative metrics provided in the summary. No positive or negative metrics are disclosed.

12-02-2026

Sadot Group Inc. filed a Form 8-K on 2026-02-12 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed. This is a multi-item mandatory disclosure of material events.

12-02-2026

Titan International Inc filed an 8-K on February 12, 2026 (AccNo: 0000899751-26-000003), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer's name, position, reason for change, appointment or departure status, or any quantitative data are disclosed in the provided filing summary.

12-02-2026

Radian Group Inc filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048971), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, or any quantitative data are explicitly stated. No positive or negative metrics, financial impacts, or governance implications are provided in the available information.

12-02-2026

Coeptis Therapeutics Holdings, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for change, timing, or any financial metrics are disclosed. No quantitative data or period-over-period comparisons provided.

12-02-2026

Limoneira CO filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, timing, or any quantitative data are disclosed.

12-02-2026

Lite Strategy, Inc. filed an 8-K on February 12, 2026, disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details including names, positions, reasons for changes, vote outcomes, or exhibit contents are NOT_DISCLOSED. No quantitative metrics, performance data, or directional implications are provided.

12-02-2026

Corebridge Financial, Inc. filed a Form 8-K on 2026-02-12 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or comparisons are disclosed.

12-02-2026

Nuburu, Inc. filed an 8-K on 2026-02-12 disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.01 completion of an acquisition or disposition of assets, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. While the completion of the transaction (Item 2.01) represents a key milestone, the new financial obligation (Item 2.03) and equity sales (Item 3.02) introduce potential leverage and dilution risks with no quantified impacts disclosed. No details on deal parties, structure, valuation, synergies, or shareholder impacts are provided.

• ·AccNo: 0001193125-26-049000
• ·Filing size: 161 KB
• ·Event date: 2026-02-12

12-02-2026

Insight Molecular Diagnostics Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, dollar values, financial impacts, or performance metrics (positive, negative, or flat) are disclosed in the provided filing summary.